COMPANY NEWS


BSE Code ISIN Demat Book Value (₹) NSE Symbol Div & Yield % Market Cap ( Cr.) P/E * EPS * Face Value (₹)
* Profit to Earning Ratio
* Earning Per Share
Shasun Pharmaceuticals temporarily suspends operations at Cuddalore API facility Back
(18 Nov 2015)
With reference to the fire accident in one of the manufacturing blocks of the Company's Cuddalore API facility, Shasun Pharmaceuticals announced that the Company have temporarily suspended the production, as directed by the Government authorities. The Company is working with the Government authorities to resume operations at the earliest.

Company confirms that there will be no material impact on the revenue of the group during the current financial year.